Study guide
5.3 Acute & Chronic Leukaemias and Lymphomas
Combined Medical Services Examination UPSC CMS
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Structure, Logistics & Pattern
1.1 UPSC CMS Examination Overview & Eligibility 1.2 Two-Paper Written Exam Pattern & Negative Marking 1.3 Personality Test, Service Allocation & Career Paths
2 Chapter 2: General Medicine - Cardiology & Respiratory
2.1 Coronary Artery Disease & Acute Myocardial Infarction 2.2 Heart Failure & Cardiac Arrhythmias 2.3 Community-Acquired Pneumonia & Pulmonary Tuberculosis 2.4 COPD, Bronchial Asthma & Pulmonary Embolism
3 Chapter 3: General Medicine - Gastroenterology & Hepatology
3.1 Peptic Ulcer Disease & Upper GI Bleeding 3.2 Liver Cirrhosis & Portal Hypertension 3.3 Acute & Chronic Viral Hepatitis & Pancreatitis 3.4 Inflammatory Bowel Disease & Malabsorption Syndromes
4 Chapter 4: General Medicine - Nephrology & Endocrinology
4.1 Acute Kidney Injury & Chronic Kidney Disease 4.2 Glomerulonephritis, Nephrotic Syndrome & Electrolyte Imbalances 4.3 Diabetes Mellitus: Diagnosis, Complications & Management 4.4 Thyroid Disorders & Adrenal Gland Dysfunction
5 Chapter 5: General Medicine - Neurology, Haematology & Infection
5.1 Cerebrovascular Accidents (Stroke) & Epilepsy 5.2 Approach to Anaemia: Microcytic, Megaloblastic & Haemolytic 5.3 Acute & Chronic Leukaemias and Lymphomas 5.4 Tropical & Endemic Infections: Malaria, Typhoid & Dengue
6 Chapter 6: General Medicine - Emergency Medicine & Toxicology
6.1 Acute Anaphylaxis, Sepsis & Cardiopulmonary Resuscitation 6.2 Organophosphate, Paracetamol & Snakebite Toxicology 6.3 Common Dermatological & Psychiatric Manifestations in Internal Medicine 6.4 Musculoskeletal System & Adult Rheumatology
7 Chapter 7: Paediatrics - Neonatology & Child Growth
7.1 Newborn Care, Neonatal Resuscitation & APGAR Score 7.2 Prematurity, Low Birth Weight & Neonatal Jaundice 7.3 Infant & Child Growth & Developmental Milestones
8 Chapter 8: Paediatrics - Child Health & Nutrition
8.1 Protein-Energy Malnutrition (PEM) & Micronutrient Deficiencies 8.2 Universal Immunization Programme (UIP) & Child Vaccines 8.3 Pediatric Diarrhoea, Dehydration & Respiratory Emergencies 8.4 Birth Defects, Genetic Counseling, Autism & Paediatric Accidents/Poisoning
9 Chapter 9: Surgery - General Surgery, Wounds & Shock
9.1 Wound Healing, Surgical Site Infections & Gas Gangrene 9.2 Pathophysiology of Shock & Perioperative Fluid Therapy 9.3 Acute Abdomen: Appendicitis, Peritonitis & Intestinal Obstruction 9.4 Classification, Resuscitation & Management of Thermal Burns 9.5 Medicolegal & Ethical Issues in Surgery
10 Chapter 10: Surgery - Surgical Specialties I
10.1 Inguinal, Femoral & Ventral Hernias 10.2 Benign Breast Diseases & Breast Carcinoma 10.3 Solitary Thyroid Nodule & Thyroid Carcinoma 10.4 Benign Prostatic Hyperplasia & Renal Calculi
11 Chapter 11: Surgery - ENT, Orthopaedics & Anaesthesia
11.1 Acute Otitis Media, Tonsillitis & Epistaxis 11.2 Cataract, Glaucoma & Red Eye Emergencies 11.3 Principles of Fracture Management & Common Dislocation 11.4 Principles of Local, Regional & General Anaesthesia 11.5 Neurosurgery: Raised ICP, Head Injury & CNS Lesions 11.6 Thoracic Surgery: Chest Trauma, Pleural & Lung Disease
12 Chapter 12: Obstetrics - Antenatal Care & Complications
12.1 Antenatal Care, Maternal Nutrition & Fetal Assessment 12.2 Preeclampsia, Eclampsia & Gestational Hypertension 12.3 Antepartum Haemorrhage: Placenta Previa & Abruptio Placentae 12.4 Anemia in Pregnancy & Gestational Diabetes Mellitus 12.5 Spontaneous & Recurrent Abortion: Recognition & Management
13 Chapter 13: Obstetrics & Gynaecology - Labor & PPH
13.1 Normal Labor Mechanisms & Partograph Monitoring 13.2 Malpresentations, Breech & Obstructed Labor 13.3 Postpartum Haemorrhage (PPH) Causes & Management 13.4 Puerperal Sepsis & Postnatal Maternal Care
14 Chapter 14: Gynaecology & Family Planning
14.1 Abnormal Uterine Bleeding & Uterine Fibroids 14.2 Cervical Screening (Pap Smear) & Pelvic Inflammatory Disease 14.3 Temporary & Permanent Contraceptive Methods in India 14.4 Medical Termination of Pregnancy (MTP): Law & Methods
15 Chapter 15: PSM - Epidemiology & Biostatistics
15.1 Principles of Epidemiology & Disease Transmission 15.2 Observational & Experimental Epidemiological Study Designs 15.3 Evaluation of Screening Tests: Sensitivity, Specificity & Predictive Value 15.4 Biostatistics: Sampling, Central Tendency & Significance Testing
16 Chapter 16: PSM - Disease Epidemiology & Programmes
16.1 Epidemiology & Control of TB, Malaria & Dengue 16.2 National Tuberculosis Elimination Programme & NVBDCP 16.3 Epidemiology of Hypertension, Diabetes & Cancer in India 16.4 Cold Chain Management & Vaccine Logistics in India 16.5 Genetics and Health: Inheritance, Screening & Counseling
17 Chapter 17: PSM - Health Planning & Environmental Health
17.1 Demography, Fertility Rates & Family Welfare Indicators 17.2 Safe Water Supply, Waste Disposal & Air Pollution 17.3 Occupational Health Hazards & Pneumoconioses 17.4 Health Care Delivery System, Ayushman Bharat & National Health Mission 17.5 International Health: WHO, Global Agencies & SDG 3 17.6 Medical Sociology & Health Education
5.3 Acute & Chronic Leukaemias and Lymphomas
Key Takeaways Explain This Topic AI
Acute Leukaemias are defined by ≥20% blasts in the bone marrow or peripheral blood; Acute Promyelocytic Leukaemia (APML / M3) harbors t(15;17) PML-RARA and is treated with All-trans Retinoic Acid (ATRA) + Arsenic Trioxide.
Chronic Myeloid Leukaemia (CML) is characterized by the t(9;22) Philadelphia chromosome creating the constitutively active BCR-ABL1 tyrosine kinase, targeted by Imatinib.
Chronic Lymphocytic Leukaemia (CLL) features mature B-cell proliferation (CD5+, CD19+, CD23+) with classic 'smudge cells' on blood film.
Classical Hodgkin Lymphoma is diagnosed by Reed-Sternberg cells (CD30+, CD15+, CD20-) and spreads predictably by contiguity.
Burkitt Lymphoma is driven by t(8;14) MYC-IGH translocation and displays a characteristic 'starry sky' appearance on lymph node biopsy.
Last updated: July 2026
Acute & Chronic Leukaemias and Lymphomas
Hematological malignancies are classified by clinical acuity (Acute vs Chronic) and lineage (Myeloid vs Lymphoid). UPSC CMS questions focus heavily on cytogenetic translocations, specific cell surface markers (CD markers), diagnostic microscopic features (Auer rods, Smudge cells, Reed-Sternberg cells, Starry sky), and targeted treatment regimens.
1. Acute Leukaemias
Acute leukaemias are rapid clonal proliferations of immature hematopoietic progenitor cells (blasts). Diagnosis requires ≥20% blasts in the bone marrow or peripheral blood.
Acute Myeloid Leukaemia (AML) vs. Acute Lymphoblastic Leukaemia (ALL)
- Feature Acute Myeloid Leukaemia (AML) Acute Lymphoblastic Leukaemia (ALL)
- Peak Age Group Adults (median age ~65 years) Children (peak age 2 - 5 years ) - most common childhood cancer
Blast Morphology Large blasts, abundant cytoplasm, Auer rods (azurophilic needle-like granules of clumped MPO). Small to medium blasts, scanty cytoplasm, fine chromatin, inconspicuous nucleoli. No Auer rods.
Cytochemistry Myeloperoxidase (MPO) positive , Sudan Black B positive. Periodic Acid-Schiff (PAS) positive , TdT (Terminal deoxynucleotidyl transferase) positive.
Immunophenotype CD13+, CD33+, CD117+, MPO+ B-ALL : CD10+ (CALLA), CD19+, CD22+; T-ALL : CD2+, CD3+, CD7+, CD8+ (presents as mediastinal mass in teen males)
Cytogenetic Pearls t(15;17) in APML (M3); t(8;21), inv(16) favorable risk. t(12;21) ETV6-RUNX1 (favorable childhood); t(9;22) BCR-ABL1 (unfavorable adult).
Special Clinical Note APML carries severe risk of fatal Disseminated Intravascular Coagulation (DIC) due to tissue factor release. Mandatory CNS prophylaxis (Intrathecal Methotrexate) required in all protocols due to blood-brain barrier sanctuary.
Acute Promyelocytic Leukaemia (APML / FAB M3)
Cytogenetics : Translocation t(15;17)(q24;q21) resulting in the PML-RARA (Promyelocytic Leukaemia - Retinoic Acid Receptor Alpha) fusion gene.
Pathophysiology : PML-RARA blocks myeloid differentiation at the promyelocyte stage.
Management : Emergency treatment with All-Trans Retinoic Acid (ATRA) + Arsenic Trioxide (ATO) . ATRA binds PML-RARA and induces promyelocytes to differentiate into mature neutrophils, dramatically reducing DIC mortality! Complication : Differentiation Syndrome (fever, pulmonary infiltrates, fluid retention treated with dexamethasone).
Loading diagram... Classification and Lineage Scheme of Hematological Malignancies
- 2. Chronic Leukaemias
- Chronic Myeloid Leukaemia (CML)
Pathogenesis : Myeloproliferative neoplasm driven by t(9;22)(q34;q11) translocation forming the Philadelphia Chromosome . This fuses BCR on chromosome 22 with ABL1 on chromosome 9, producing a constitutively active p210 BCR-ABL1 tyrosine kinase .
Clinical Features : Marked splenomegaly (often giant / extending into right iliac fossa), fatigue, night sweats, hyperuricemia.
Laboratory Findings : Extreme leukocytosis (WBC often >100,000/mm³) with the entire spectrum of myeloid differentiation present in peripheral blood (neutrophils, band forms, metamyelocytes, myelocytes, promyelocytes). Marked basophilia and eosinophilia.
Key Diagnostic Marker : Leukocyte Alkaline Phosphatase (LAP) / Neutrophil Alkaline Phosphatase (NAP) score is LOW / ZERO in CML (differs from leukemoid reaction where LAP score is markedly high).
Disease Phases : Chronic phase -> Accelerated phase -> Blast Crisis (conversion to AML [70%] or ALL [30%]).
Targeted Therapy : Imatinib Mesylate (first-generation Tyrosine Kinase Inhibitor / TKI binding the ATP-binding pocket of BCR-ABL1). Second-generation TKIs: Dasatinib, Nilotinib.
Chronic Lymphocytic Leukaemia (CLL)
Pathogenesis : Clonal expansion of morphologically mature but functionally incompetent B lymphocytes.
Immunophenotype : CD5+ (T-cell marker aberrantly expressed on B cells), CD19+, CD20+ (weak), CD23+ , with surface immunoglobulin (sIg) positivity.
Peripheral Smear : Marked absolute lymphocytosis with characteristic Smudge cells / Basket cells (Gumprecht shadows - fragile CLL cells disrupted during slide preparation).
Complications : Hypogammaglobulinemia (recurrent bacterial infections), Autoimmune Haemolytic Anaemia (warm IgG AIHA in 10-15%), and Richter Transformation (sudden transformation into aggressive Diffuse Large B-Cell Lymphoma / DLBCL).
- 3. Lymphomas & Multiple Myeloma
- Hodgkin Lymphoma (HL) vs. Non-Hodgkin Lymphoma (NHL)
Feature Hodgkin Lymphoma (HL) Non-Hodgkin Lymphoma (NHL)
Nodal Spread Contiguous, orderly spread along adjacent node chains Non-contiguous, erratic, widespread nodal involvement
Extranodal Involvement Rare Common (GI tract, bone marrow, brain)
Pathognomonic Cell Reed-Sternberg (RS) Cell : Binucleated cell with prominent inclusion-like nucleoli ( "owl's eye" appearance ). Absence of classic RS cells; monoclonal proliferation of B (85%) or T (15%) cells.
RS Immunophenotype CD30+, CD15+ , CD20- (in Classical HL) CD20+ (B-cell NHLs, e.g., DLBCL, Follicular).
Histological Subtypes Nodular Sclerosis (most common, collagen bands, lacunar RS cells, young females); Mixed Cellularity (associated with EBV); Lymphocyte Rich; Lymphocyte Depleted (worst prognosis). Burkitt Lymphoma : t(8;14) MYC-IGH, "starry sky" pattern (tingible body macrophages among apoptotic blasts). Associated with EBV in endemic jaw tumor.; DLBCL : Most common adult NHL, aggressive, CD20+.
Clinical Staging Ann Arbor Staging : Stage I (single node region) to Stage IV (disseminated extranodal). Sub-classified by A (no B symptoms) or B (Fever >38°C, drenching night sweats, unexplained weight loss >10% over 6 months).
Chemotherapy Regimen ABVD : Adriamycin (Doxorubicin), Bleomycin, Vinblastine, Dacarbazine. R-CHOP : Rituximab (anti-CD20), Cyclophosphamide, Hydroxydaunorubicin, Oncovin (Vincristine), Prednisone.
Multiple Myeloma
Multiple Myeloma is a malignant plasma cell dyscrasia producing monoclonal immunoglobulin (most commonly IgG [55%] or IgA [20%] ).
Diagnostic CRAB Criteria :
C - Hypercalcaemia : Serum Calcium >11 mg/dL (due to osteoclast activating factors MIP-1α, RANKL).
R - Renal Insufficiency : Serum Creatinine >2 mg/dL (Light chain cast nephropathy / Bence-Jones proteinuria forming tubular casts).
A - Anaemia : Normocytic normochromic (Hb <10 g/dL due to marrow replacement).
B - Bone Lesions : Multiple punched-out lytic lesions on X-ray (skull, spine, pelvis); pathological fractures; severe back pain.
Laboratory & Smear Findings :
Bone marrow aspirate shows ≥10% clonal plasma cells (eccentric nucleus, "clock-face" / "radially arranged" chromatin, perinuclear halo).
Serum Protein Electrophoresis (SPEP) : Sharp M-spike in gamma-globulin region.
Peripheral smear: Rouleaux formation (stacked coin appearance of RBCs due to elevated monoclonal antibodies neutralizing electrostatic repulsive charge).